These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 21459674)

  • 1. Mucosal-associated invariant T cells: unconventional development and function.
    Le Bourhis L; Guerri L; Dusseaux M; Martin E; Soudais C; Lantz O
    Trends Immunol; 2011 May; 32(5):212-8. PubMed ID: 21459674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1.
    Treiner E; Duban L; Bahram S; Radosavljevic M; Wanner V; Tilloy F; Affaticati P; Gilfillan S; Lantz O
    Nature; 2003 Mar; 422(6928):164-9. PubMed ID: 12634786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells.
    Sharma PK; Wong EB; Napier RJ; Bishai WR; Ndung'u T; Kasprowicz VO; Lewinsohn DA; Lewinsohn DM; Gold MC
    Immunology; 2015 Jul; 145(3):443-53. PubMed ID: 25752900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.
    Chua WJ; Truscott SM; Eickhoff CS; Blazevic A; Hoft DF; Hansen TH
    Infect Immun; 2012 Sep; 80(9):3256-67. PubMed ID: 22778103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAIT cells and MR1-antigen recognition.
    Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.
    Gold MC; Napier RJ; Lewinsohn DM
    Immunol Rev; 2015 Mar; 264(1):154-66. PubMed ID: 25703558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers.
    Rahimpour A; Koay HF; Enders A; Clanchy R; Eckle SB; Meehan B; Chen Z; Whittle B; Liu L; Fairlie DP; Goodnow CC; McCluskey J; Rossjohn J; Uldrich AP; Pellicci DG; Godfrey DI
    J Exp Med; 2015 Jun; 212(7):1095-108. PubMed ID: 26101265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR1 presentation of vitamin B-based metabolite ligands.
    McWilliam HE; Birkinshaw RW; Villadangos JA; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2015 Jun; 34():28-34. PubMed ID: 25603223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
    López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
    Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAIT cell recognition of MR1 on bacterially infected and uninfected cells.
    Young MH; U'Ren L; Huang S; Mallevaey T; Scott-Browne J; Crawford F; Lantz O; Hansen TH; Kappler J; Marrack P; Gapin L
    PLoS One; 2013; 8(1):e53789. PubMed ID: 23342002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution.
    Huang S; Martin E; Kim S; Yu L; Soudais C; Fremont DH; Lantz O; Hansen TH
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8290-5. PubMed ID: 19416870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.
    Chen Z; Wang H; D'Souza C; Sun S; Kostenko L; Eckle SB; Meehan BS; Jackson DC; Strugnell RA; Cao H; Wang N; Fairlie DP; Liu L; Godfrey DI; Rossjohn J; McCluskey J; Corbett AJ
    Mucosal Immunol; 2017 Jan; 10(1):58-68. PubMed ID: 27143301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
    Zumwalde NA; Haag JD; Gould MN; Gumperz JE
    Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
    Kawachi I; Maldonado J; Strader C; Gilfillan S
    J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage.
    Gold MC; McLaren JE; Reistetter JA; Smyk-Pearson S; Ladell K; Swarbrick GM; Yu YY; Hansen TH; Lund O; Nielsen M; Gerritsen B; Kesmir C; Miles JJ; Lewinsohn DA; Price DA; Lewinsohn DM
    J Exp Med; 2014 Jul; 211(8):1601-10. PubMed ID: 25049333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAITs, MR1 and vitamin B metabolites.
    Birkinshaw RW; Kjer-Nielsen L; Eckle SB; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2014 Feb; 26():7-13. PubMed ID: 24556396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.